Nasir, Khurram
Houston Methodist
39 papers on CoChatORCID 0000-0001-5376-2269
Most cited papers
- Verified
Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events—Implications for the Use of Preventive Pharmacotherapy
Bittencourt, M. S., Blaha, M. J., Blankstein, R., Budoff, M., Vargas, J. D., Blumenthal, R. S., Agatston, A. S., & Nasir, K. (2014) · Journal of the American College of Cardiology
Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health
Cited by 70
- Verified
Nativity-Related Disparities in Preeclampsia and Cardiovascular Disease Risk Among a Racially Diverse Cohort of US Women
Boakye, E., Kwapong, Y. A., Obisesan, O., Ogunwole, S. M., Hays, A. G., Nasir, K., Blumenthal, R. S., Douglas, P. S., Blaha, M. J., Hong, X., et al. (2021) · JAMA Network Open
Pregnancy and preeclampsia studiesNeurological Complications and Syndromes
Cited by 69
- Verified
Assessment of Subclinical Coronary Atherosclerosis in Asymptomatic Patients With Type 2 Diabetes Mellitus With Single Photon Emission Computed Tomography and Coronary Computed Tomography Angiography
Choi, E.-K., Chun, E. J., Choi, S.-I., Chang, S.-A., Choi, S.-H., Lim, S., Rivera, J. J., Nasir, K., Blumenthal, R. S., Jang, H.-C., et al. (2009) · The American Journal of Cardiology
Cardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 57
- Verified · note
Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey
Valero-Elizondo, J., Salami, J. A., Ogunmoroti, O., Osondu, C. U., Aneni, E. C., Malik, R., Spatz, E. S., Rana, J. S., Virani, S. S., Blankstein, R., et al. (2016) · Circulation: Cardiovascular Quality and Outcomes
Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention
Cited by 51
- Verified
Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
Satish, P., Sadaf, M. I., Valero-Elizondo, J., Grandhi, G. R., Yahya, T., Zawahir, H., Javed, Z., Mszar, R., Hanif, B., Kalra, A., et al. (2021) · American Journal of Preventive Cardiology
Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors
Cited by 48
- Verified
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
Naghavi, M., Reeves, A. P., Atlas, K., Zhang, C., Atlas, T., Henschke, C. I., Yankelevitz, D. F., Budoff, M. J., Li, D., Roy, S. K., et al. (2024) · npj Digital Medicine
Cardiac Imaging and DiagnosticsArtificial Intelligence in Healthcare and Education
Cited by 45
- Verified
Optimal screening for predicting and preventing the risk of heart failure among adults with diabetes without atherosclerotic cardiovascular disease: a pooled cohort analysis
Patel, K. V., Segar, M. W., Klonoff, D. C., Khan, M. S., Usman, M. S., Lam, C. S. P., Verma, S., DeFilippis, A. P., Nasir, K., Bakker, S. J. L., et al. (2024) · Circulation
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 38
- Verified
Favorable Cardiovascular Health Is Associated With Lower Health Care Expenditures and Resource Utilization in a Large US Employee Population
Osondu, C. U., Aneni, E. C., Valero-Elizondo, J., Salami, J. A., Rouseff, M., Das, S., Guzman, H., Younus, A., Ogunmoroti, O., Feldman, T., et al. (2017) · Mayo Clinic Proceedings
Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention
Cited by 32
- Verified
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
Taha, M. B., Yahya, T., Satish, P., Laird, R., Agatston, A. S., Cainzos-Achirica, M., Patel, K. V., & Nasir, K. (2022) · Current Atherosclerosis Reports
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 31
- Verified
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists
Dani, S. S., Makwana, B., Khadke, S., Kumar, A., Jhund, P., Nasir, K., Sattar, N., Al-Kindi, S., Fonarow, G., Butler, J., et al. (2025) · JACC: Advances
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 30
- Verified
Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Jamal, O., Aneni, E. C., Shaharyar, S., Ali, S. S., Parris, D., McEvoy, J. W., Veledar, E., Blaha, M. J., Blumenthal, R. S., Agatston, A. S., et al. (2014) · Diabetology & Metabolic Syndrome
Adipokines, Inflammation, and Metabolic DiseasesSmoking Behavior and Cessation
Cited by 30
- Verified
CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular Disease
Cainzos-Achirica, M., Quispe, R., Dudum, R., Greenland, P., Lloyd-Jones, D., Rana, J. S., Lima, J. A. C., Doria de Vasconcellos, H., Joshi, P. H., Khera, A., et al. (2022) · JACC: Cardiovascular Imaging
Cardiac Imaging and DiagnosticsLipoproteins and Cardiovascular Health
Cited by 24
- Verified
Traditional cardiovascular disease risk factors associated with one-year all-cause mortality among those with coronary artery calcium scores ≥400
Al Rifai, M., McEvoy, J. W., Nasir, K., Rumberger, J., Feldman, D., Budoff, M. J., & Blaha, M. J. (2015) · Atherosclerosis
Cardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 12
- Verified
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS)
Feldman, D. I., Valero-Elizondo, J., Salami, J. A., Rana, J. S., Ogunmoroti, O., Osondu, C. U., Spatz, E. S., Virani, S. S., Blankstein, R., Blaha, M. J., et al. (2017) · Atherosclerosis
Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention
Cited by 11
- Verified
Tracking the Preclinical Progression of Transthyretin Amyloid Cardiomyopathy Using Artificial Intelligence-Enabled Electrocardiography and Echocardiography
Oikonomou, E. K., Sangha, V., Vasisht Shankar, S., Coppi, A., Krumholz, H. M., Nasir, K., Miller, E. J., Gallegos-Kattan, C., Al-Mallah, M. H., Al-Kindi, S., et al. (2024) · medRxiv
Amyloidosis: Diagnosis, Treatment, OutcomesArtificial Intelligence in Healthcare and Education
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free